These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24522401)

  • 41. Prognostic prediction models for chronic postsurgical pain in adults: a systematic review.
    Papadomanolakis-Pakis N; Uhrbrand P; Haroutounian S; Nikolajsen L
    Pain; 2021 Nov; 162(11):2644-2657. PubMed ID: 34652320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
    Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
    BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
    JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sun Protection and Skin Examination Practices in a Setting of High Ambient Solar Radiation: A Population-Based Cohort Study.
    Olsen CM; Thompson BS; Green AC; Neale RE; Whiteman DC;
    JAMA Dermatol; 2015 Sep; 151(9):982-90. PubMed ID: 26039788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Skin pigmentation, nevi and sunshine as etiological factors in cutaneous malignant melanoma].
    Osterlind A; Jensen OM
    Nord Med; 1990; 105(8-9):223-9. PubMed ID: 2216688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of primary cutaneous malignant melanoma: increasing cure rate in the 1990's.
    Roy MA; Wagner RF
    Cutis; 1992 Nov; 50(5):365-70. PubMed ID: 1468259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.
    Kaiser I; Mathes S; Pfahlberg AB; Uter W; Berking C; Heppt MV; Steeb T; Diehl K; Gefeller O
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards the best kidney failure prediction tool: a systematic review and selection aid.
    Ramspek CL; de Jong Y; Dekker FW; van Diepen M
    Nephrol Dial Transplant; 2020 Sep; 35(9):1527-1538. PubMed ID: 30830157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.
    Markovic SN; Erickson LA; Rao RD; Weenig RH; Pockaj BA; Bardia A; Vachon CM; Schild SE; McWilliams RR; Hand JL; Laman SD; Kottschade LA; Maples WJ; Pittelkow MR; Pulido JS; Cameron JD; Creagan ET;
    Mayo Clin Proc; 2007 Mar; 82(3):364-80. PubMed ID: 17352373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models.
    Stevenson JM; Williams JL; Burnham TG; Prevost AT; Schiff R; Erskine SD; Davies JG
    Clin Interv Aging; 2014; 9():1581-93. PubMed ID: 25278750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Prediction Model for Esophageal Cancer Among General Population: A Systematic Review.
    Chen R; Zheng R; Zhou J; Li M; Shao D; Li X; Wang S; Wei W
    Front Public Health; 2021; 9():680967. PubMed ID: 34926362
    [No Abstract]   [Full Text] [Related]  

  • 52. [Progress in construction and verification of colorectal cancer risk prediction models: a systematic review].
    Guo LW; Li N; Chen HD; Lyu ZY; Feng XS; Wei LP; Li X; Wen Y; Lu M; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jun; 53(6):603-610. PubMed ID: 31177758
    [No Abstract]   [Full Text] [Related]  

  • 53. Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.
    Williams LH; Shors AR; Barlow WE; Solomon C; White E
    J Clin Exp Dermatol Res; 2011; 2(6):. PubMed ID: 22229112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent development of risk-prediction models for incident hypertension: An updated systematic review.
    Sun D; Liu J; Xiao L; Liu Y; Wang Z; Li C; Jin Y; Zhao Q; Wen S
    PLoS One; 2017; 12(10):e0187240. PubMed ID: 29084293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood prediction models for hypertension later in life: a systematic review.
    Hamoen M; de Kroon MLA; Welten M; Raat H; Twisk JWR; Heymans MW; Vergouwe Y
    J Hypertens; 2019 May; 37(5):865-877. PubMed ID: 30362985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The c-index is not proper for the evaluation of $t$-year predicted risks.
    Blanche P; Kattan MW; Gerds TA
    Biostatistics; 2019 Apr; 20(2):347-357. PubMed ID: 29462286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in the conduct and reporting of clinical prediction model development and validation: a systematic review.
    Yang C; Kors JA; Ioannou S; John LH; Markus AF; Rekkas A; de Ridder MAJ; Seinen TM; Williams RD; Rijnbeek PR
    J Am Med Inform Assoc; 2022 Apr; 29(5):983-989. PubMed ID: 35045179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical Primer: developing and validating a risk prediction model.
    Grant SW; Collins GS; Nashef SAM
    Eur J Cardiothorac Surg; 2018 Aug; 54(2):203-208. PubMed ID: 29741602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting melanoma risk: theory, practice and future challenges.
    Whiteman D
    Melanoma Manag; 2014 Nov; 1(2):105-114. PubMed ID: 30190816
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.